Seeking Alpha

Amarin (AMRN +0.3%) says the USPTO has published notification of Notice of Allowance for an...

Amarin (AMRN +0.3%) says the USPTO has published notification of Notice of Allowance for an application to protect its heart pill Vascepa, which was approved in July by the FDA. The application is a continuation of its earlier patent, and broadens its claims by guaging the drugs effects against a subject's own baseline, as well as on a patient population basis. An earlier application granted last week had been guaged only against a placebo control group.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs